Drugs / EVARREST Fibrin Sealant Patch
EVARREST Fibrin Sealant Patch
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03255174 | Mar 2018 → Jan 2025 | — | Ethicon, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVARREST Fibrin Sealant Patch | “EVARREST Fibrin Sealant Patch is a sterile, bio-absorbable combination product consisting of two constituent parts- a flexible matrix and a coating of biological components...” NCT03255174 ↗ |
| Modality | Protein / enzyme biologic | “biological components (human plasma-derived fibrinogen and thrombin)” NCT03255174 ↗ |